Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology 2022-09-28 16:00
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib 2022-09-28 13:00
ETANA HAS SECURED B ROUND FINANCING 2022-09-28 09:00
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate 2022-09-28 06:50
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
CP KELCO PARTNERS WITH EXOPOLYMER TO BRING NEXT-GENERATION FUNCTIONAL BIOPOLYMERS TO MARKET 2022-09-27 21:00
Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study 2022-09-27 19:57
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics 2022-09-27 08:00
First Patient Enrolled in ProstACT TARGET Study 2022-09-27 05:00
Bioheng Biotech Announces Publication of Impressive Results with CD7-targeted allogeneic CAR-T cell therapy for Relapsed or Refractory T Cell Malignancies 2022-09-26 21:00
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression 2022-09-26 20:00
PharmAbcine to Participate in BIO-Europe 2022 2022-09-26 20:00
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility 2022-09-26 20:00
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world's premier diabetic foot conference (DFCon) in Los Angeles 2022-09-26 13:44
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy 2022-09-26 12:31
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases 2022-09-26 08:00
Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities 2022-09-23 17:00
WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED 2022-09-22 21:25
Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 2022-09-22 13:59
Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug's Best-in-Class Potential 2022-09-21 22:49
1 113 114 115 116 117 414